<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 19, 1998
---------------
HEALTHDESK CORPORATION
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
<S> <C> <C>
California 0-21819 94-3165144
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer)
incorporation or organization) Identification No.)
</TABLE>
2560 Ninth Street, Suite 220 94710
Berkeley, California
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (510) 883-2160
<PAGE>
Item 5. Other Events.
On February 19, February 24, and February 25, 1998, the
Company completed the sale of 300,000, 50,000 and 50,000
shares of Common Stock for aggregate gross proceeds of
$600,000, $100,000, and $100,000, respectively.
Item 7. Exhibits.
(a) The following Exhibit is attached hereto and filed hereby:
99.1 Unaudited Statement of Operations for the one month
ended January 31, 1998, and pro-forma unaudited
Balance Sheets as of January 31, 1998, giving
effect to the $800,000 in proceeds from Common
Stock sales received in February 1998
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
HEALTHDESK CORPORATION.
Date: February 25, 1998 By: /s/ Timothy S. Yamauchi
------------------------------
Timothy S. Yamauchi,
Chief Financial Officer, Secretary and
Treasurer
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
Sequentially
Exhibit Document Numbered Page
------- -------- ---------------
<S> <C> <C>
99.1 Unaudited Statement of Operations for the one month ended January 31,
1998, and pro-forma unaudited Balance Sheets as of January 31, 1998.
</TABLE>
<PAGE>
HealthDesk Corporation
(a Development Stage Company)
Exhibit 99.1
INTERIM BALANCE SHEETS
(unaudited)
<TABLE>
<CAPTION>
Pro-forma
January 31, Financing January 31,
ASSETS 1998 Impact 1998
---- ------ ----
<S> <C> <C> <C>
Current assets:
Cash and cash equivalents....................... $ 1,085,925 $ 800,000 $ 1,885,925
Prepaid expenses and other...................... 89,087 ---- 89,087
---------------- ---------------- ----------------
Total current assets....................... 1,175,012 800,000 1,975,012
Property and equipment, net....................... 449,527 ---- 449,527
Other assets...................................... 19,612 ---- 19,612
---------------- ---------------- ----------------
Total assets............................... $ 1,644,151 $ 800,000 $ 2,444,151
================ ================ ================
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable............................... $ 87,331 ---- $ 87,331
Accrued liabilities............................ 318,100 ---- 318,100
---------------- ---------------- ----------------
Total liabilities.......................... 405,431 ---- 405,431
---------------- ---------------- ----------------
Shareholders' equity:
Common stock, no par value; authorized
17,000,000 shares; issued and outstanding and
5,392,845 shares at January 31, 1998, and
pro-forma 5,792,845, respectively............ 11,457,505 800,000 12,257,505
Warrants....................................... 195,687 ---- 195,687
Deficit accumulated during the development
stage........................................ (10,414,472) ---- (10,414,472)
----------------- ---------------- -----------------
Total shareholders' equity ....................... 1,238,720 800,000 2,038,720
---------------- ---------------- ----------------
Total liabilities and shareholders' equity $ 1,644,151 $ 800,000 $ 2,444,151
================ ================ ================
</TABLE>
<PAGE>
HealthDesk Corporation
(a Development Stage Company)
Exhibit 99.1
STATEMENT OF OPERATIONS
(unaudited)
Month Ended
January 31, 1998
Revenue:
Software development and licensing....... $ ----
Other.................................... 370
----------------
Total revenue........................ 370
----------------
Costs and expenses:
Product development...................... 145,865
Sales and marketing...................... 96,291
General and administrative............... 12,164
----------------
Total costs and expenses............. 254,320
Loss from operations................... (253,950)
Interest income.......................... 5,234
----------------
Loss before income taxes............... (248,716)
Provision for income taxes.................. (67)
-----------------
Net loss................................ $ (248,783)
=================
